Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In SituE. Shelley Hwang, Doreen M. Agnese, Deborah Collyar et al.|JAMA|2024Cited by 75
Illness Understanding of Oncology Patients in a Community-Based Cancer InstituteShanthi Sivendran, Manshu Yang, Sarah M. Jenkins et al.|Journal of Oncology Practice|2017Cited by 20
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In SituAnn H. Partridge, Kimberly Strickland, Terry Hyslop et al.|JAMA Oncology|2024Cited by 16
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United StatesChristopher R. Flowers, James R. Cerhan, Brian K. Link et al.|Blood|2018Cited by 9
Illness understanding of oncology patients in a community-based cancer institute.Shanthi Sivendran, Manshu Yang, Sarah M. Jenkins et al.|Journal of Clinical Oncology|2017Cited by 1